Evidence map›Paper›PMID 33897046›Full record

ArticleThe Linacre quarterly2021

Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged.

William V Williams, Joel Brind, Laura Haynes, Michael D Manhart, Hanna Klaus, Angela Lanfranchi, Gerard Migeon, Mike Gaskins, Elvis I Seman, Lester Ruppersberger and 1 more

Abstract read
In one paragraph

Article in The Linacre quarterly, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Safety and effectiveness of seahorse extract (Journal of advanced veterinary and animal research · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

William V WilliamsBriaCell Therapeutics Corporation, Berkeley, CA, USA.ORCID https://orcid.org/0000-0003-3611-9284
Joel BrindBreast Cancer Prevention Institute, Whitehouse Station, NJ, USA.
Laura HaynesInternational Federation for Therapeutic and Counseling Choice, General Board Member and USA Country Representative, Tustin, California, USA.
Michael D ManhartCouple to Couple League, Cincinnati, OH, USA.ORCID https://orcid.org/0000-0003-1727-1846
Hanna KlausCatholic Medical Association, Fort Washington, PA, USA.
Angela LanfranchiCatholic Medical Association, Fort Washington, PA, USA.
Gerard MigeonNatural Womanhood, San Antonio, TX, USA.
Mike GaskinsIndependent Author, Ft. Worth, TX, USA.
Elvis I SemanAssociate Professor of Obstetrics, Gynaecology and Reproductive Medicine, Flinders University, Adelaide, South Australia.
Lester RuppersbergerCatholic Medical Association, Fort Washington, PA, USA.
Kathleen M RavieleCatholic Medical Association, Fort Washington, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hormonal contraceptives have been on the market for over fifty years and, while their formulations have changed, the basic mechanism of action has remained the same. During this time, numerous studies have been performed documenting side effects, some of which appear over time, some within weeks or months, but all can have a serious impact on health and quality of life. An effort was made to perform a series of comprehensive literature surveys to better understand immediate and long-term side effects of these agents. The results of this literature review uncovered a number of potential side effects, some of which are acknowledged and many of which are not noted in the prescribing information for these agents. Among the unacknowledged side effects are: an increased risk of HIV transmission for depot medroxyprogesterone acetate (DMPA), and for combination contraceptives breast cancer, cervical cancer, Crohn's disease, ulcerative colitis, systemic lupus erythematosus, depression, mood disorders and suicides (especially among women twenty-five years of age and younger, in the first six months of use), multiple sclerosis, interstitial cystitis, female sexual dysfunction, osteoporotic bone fractures (especially for progesterone-only contraceptives), and fatty weight gain. Misleading prescribing information regarding cardiovascular and thrombotic risks are also noted. Women seeking birth control have a right to be informed and educated about risk avoidance through the use of effective nonhormonal methods like fertility awareness methods. In one case-that of DMPA-the increased risk of HIV acquisition has been conclusively demonstrated to be both real and unique to this drug. Considering the availability of numerous alternatives, there is no justification for the continued marketing of DMPA to the public. SUMMARY: We reviewed the effect of hormonal contraceptives on women's health. A number of potential side effects were noted including increased risks of breast cancer, cervical cancer, inflammatory bowel  disease, lupus, multiple sclerosis, cystitis, bone fractures, depression, mood disorders and suicides,  fatty weight gain, and female sexual dysfunction.  With the long-acting injectable contraceptives there is an increased risk of getting HIV.  Misleading prescribing information regarding the risks of heart attacks, strokes and blood clotting problems were also noted. Women seeking birth control have a right to know about how to avoid these risks by using effective hormone-free Fertility Awareness Methods.

Indexed as

Autoimmune diseaseCancerContraceptionFracturesHuman immunodeficiency virusOsteoporosisSexual dysfunctionSuicideThromboembolic diseaseWeight gain

Identifiers

PMID33897046
PMCPMC8033491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.